Navigation Links
Sunridge Announces Marketing Roll Out of PNT in the Dominican Republic

FOUNTAIN HILLS, Ariz., Feb. 17 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ) announced today that it will be sending a medical team to the Dominican Republic the first week in March to assist S3G with its marketing efforts.

S3G is the exclusive distributor for Pneumatic Trabeculoplasty "PNT" and its disposable product line in the Dominican Republic.  

Having completed a successful seminar with 10 local doctors, S3G received orders for a dozen units and the disposable rings use in the PNT treatment of glaucoma.

"We are going to send in medical personnel to treat patients and teach these initial doctors in the use of the equipment," states G. Richard Smith, CEO of Sunridge (  "While there, we will assist with two additional seminars being held in Santiago and Santo Domingo where we expect 50 or more doctors in attendance."

Sam Amegan, S3G's president said, "I want to build off the success of our first seminar.  We have a great deal of interest from the doctors here because glaucoma is such an alarming problem in this country.  It affects over a million people."  Sam goes on to say, "PNT is important because not only is it safe and effective as a treatment, but it is cost effective and affordable to people who might not be able to afford getting treatment otherwise."

"This is going to be a very strong market for our disposable line because of the unusually high incidence of glaucoma in this population.  Once success is proven here, we can expect rapid expansion throughout the rest of the Caribbean," states Mr. Smith.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide.  PNT has been proven (through studies completed over the last 10 yrs) to be a safe and effective treatment with no adverse side effects associated with it, unlike typical forms of glaucoma treatment.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

CONTACT:  Jeff Smith of Sunridge International, +1-480-837-6165,

SOURCE Sunridge International



SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
2. Otix Global Announces Results for Fourth Quarter 2009
3. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
4. PatientSafe Solutions, Inc. Announces Management Team
5. Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination) Test
6. CalciMedica Announces Issuance of US Patent No. 7,645,588, a Composition Patent Involving STIM1, a Key Component of the CRAC Channel
7. VetCentric Announces Partnership With Pfizer Animal Health
8. Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R)
9. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
10. Health Robotics Announces Successful Transition to new and Distinctively Superior Distribution Channels in North America
11. Amnis Announces Record 2009 Sales
Post Your Comments:
(Date:10/12/2015)... October 12, 2015 ... to grow at 7.2% CAGR, microscopy market ... rising focus on nanotechnology, technological advancements, and ... report available with ... . --> Complete report on ...
(Date:10/12/2015)...   Royal Philips (NYSE: PHG, AEX: PHIA), ... a collaboration with Genomic Health , Inc. (NASDAQ: ... diagnostic tests, to leverage Philips digital pathology tools in ... testing processes.    --> ... samples and plays a crucial role in the diagnosis ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: ... District of Delaware granted the Company,s ... Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to market ... (buprenorphine and naloxone) Sublingual Film (CIII) in the ... --> Since August 2013, Indivior has received Paragraph IV ...
Breaking Medicine Technology:
(Date:10/12/2015)... ... 2015 , ... The American Society of Clinical Hypnosis (ASCH) ... and clinical training in a health care discipline. , Many practitioners claim ... losing weight, managing pain, or stopping smoking, etc. Frequently, extravagant statements and guarantees ...
(Date:10/12/2015)... ... October 12, 2015 , ... AcousticSheep LLC, creators of ... in honor of Breast Cancer Awareness Month. During the month of October, ... a SleepPhones® Classic product to a breast cancer patient at the Cleveland Clinic. ...
(Date:10/12/2015)... ... October 12, 2015 , ... To help ... its charitable donation to the National Breast Cancer Foundation. The National Breast Cancer ... breast cancer through early detection, education, and support services. , The annual campaign ...
(Date:10/12/2015)... ... October 12, 2015 , ... NFL football fans who are interested in having an opportunity to ... CLICK HERE to donate to Smile for a Lifetime (S4L) Foundation and gift ... all-inclusive trip to the 2016 NFL Super Bowl! , Donors contributing $20.00 or more between ...
(Date:10/12/2015)... , ... October 12, 2015 , ... The translation for ... seamless migration of complete ARIS installations into the Microsoft world. The ARIS models ... As Microsoft Visio® is very familiar for both IT and Office users it is ...
Breaking Medicine News(10 mins):